|
|
|
|
|
|
A Weekly Health Policy Round Up From Health Affairs
November 29, 2020
|
|
|
|
|
|
|
|
|
COVID-19
How One Foundation Is Using Research To Enhance Its COVID-19 Response Grant Making
By Sophie Wheelock, Mark A. Zezza, and David Sandman (11/24/20)
Dedicating certain staffers and funding to research and analytics can help foundations target their grant making to those most in need and provide important information to grantees, especially during the COVID-19 pandemic.The New York State Health Foundation, with a longstanding practice of doing research and data analysis, for example, analyzed near real-time US Census Bureau data to determine food scarcity trends in the state during the pandemic. Read More >>
Factors That Shape Notification Of Health Care Outbreaks Of COVID-19
By Martha Ngoh, Kate Heyer, Maureen Tierney, Dawn Terashita, and Moon Kim (11/24/20)
Collaborative and coordinated efforts between public health agencies and health care facilities to manage notification of COVID-19 outbreaks in health care facilities can help prevent and control the spread of the virus. Read More >>
DISPARITIES
Health Equity Should Be A Key Value In Value-Based Payment And Delivery Reform
By Sahil Sandhu, Robert S. Saunders, Mark B. McClellan, and Charlene A. Wong (11/25/20)
The COVID-19 pandemic has hastened the need to prioritize health equity in value-based payment reform. Going beyond identifying the persistent health disparities in our system will require taking concrete steps related to performance measurement, reimbursement, and care delivery. Read More >>
Ten Urgent Reforms To Protect The CDC And FDA From Harmful Political Interference
By Peter Suwondo, Timothy Westmoreland, and Howard P. Forman (11/24/20)
Confidence in our health agencies is key to saving lives, and we have seen the damage that comes from their politicization. The time has come to ensure that nothing similar ever happens again. Read More
>>
PHARMACEUTICALS & MEDICAL TECHNOLOGY
Balancing Lower US Prescription Drug Prices And Innovation—Part 2
By Steven M. Lieberman, Paul B. Ginsburg, and Kavita Patel (11/25/20)
Balancing the tension between lowering U.S. drug prices while sustaining robust research and development investment poses a complex challenge for policymakers and raises the fundamental question addressed in this two-part blog post: how can the U.S. minimize the adverse effects of lower drug prices on innovation? Read More >>
Administration Finalizes Most-Favored-Nation Drug
Pricing Rule At The Last MinuteBy Rachel Sachs (11/23/20) As published in Interim Final Rule (IFR) form, the most-favored-nation rule has changed in several important respects since its initial introduction more than two years ago. For example, the IFR imposes a mandatory nationwide program and jettisons the complex vendor model that supported the original proposal. Read More >>Administration Finalizes Drug Pricing Rebate Rule At The Last MinuteBy Rachel Sachs (11/23/20) As originally proposed, the rebate rule would have applied not only to Medicare Part D but also to Medicaid Managed Care Organizations. CMS decided to remove Medicaid MCOs from the scope of the safe harbor changes in the final rebate rule. Also, Secretary Azar confirmed that the rule is not projected to increase federal spending, Medicare beneficiary premiums, or patients’ total out-of-pocket costs, despite CMS estimates to the contrary. Read More >>
|
|
|
|
|
|
|
EYE ON HEALTH REFORM
The Election; The ACA At The Supreme Court
By Katie Keith
With states poised to certify the results of the 2020 presidential election, Katie Keith outlines the likely legislative priorities for a Biden administration. She also outlines the possible paths for the Supreme Court’s decision in California v. Texas, a case that challenges the constitutionality of the Affordable Care Act. Read More >>
|
|
|
THE PRACTICE OF MEDICINE
Meaningful Use And Medical Home Functionality In Primary Care Practice
By Diane R. Rittenhouse, James A. Wiley, Lars E. Peterson, Lawrence P. Casalino, and Robert L. Phillips
To improve health care quality and decrease costs, both the public and private sectors continue to make substantial investments in the transformation of primary care. Central to these efforts is the patient-centered medical home (PCMH) model and the adoption and meaningful use of health information technology (IT). Diane Rittenhouse and coauthors used 2018 national family medicine data to provide a perspective on the implementation of PCMH and health IT elements in a variety of US physician practices. Read More >>
This paper appears in an ongoing Health Affairs article series, The Practice of Medicine, which is supported by The Physicians Foundation.
|
|
|
|
|
New podcast!
Listen to Alan Weil interview Angela Shen, lead author of today's featured article, on equitable access to a COVID-19 vaccine once it's available.
Listen here.
|
|
|
|
|
|
|
|
|
|
|
|
|
About Health Affairs
Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print
and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States
Privacy Policy
|
|
|
|
|
